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1. Introduction 
Chloramphenicol is one of a number of antibiotics 
which specifically inhibit mitochondrial protein syn- 
thesis in eukaryotic cells, while not affecting the cyto- 
plasmic system [ 1,2]. Some mutations conferring 
resistance to chloramphenicol could directly affect the 
mitochondrial protein synthesizing system. Studies of 
respiratory-deficient mutants of yeast and of Neuro- 
spora have shown that mitochondrial proteins are pro- 
ducts of both cytoplasmic extrachromosomal deter- 
minants and of chromosomal genes [3]. The Neuro 
spora poky mutation, which affects mitochondrial 
ribosomes, exhibits nonMendelian inheritance [4]. The 
existence of erythromycin-, mikamycin-, and chloram- 
phenicol-resistant yeast mutants which likewise show 
cytoplasmic inheritance [5-S] suggest hat, in mam- 
malian cells also, resistance to chloramphenicol may 
be mitochondrially coded. 
Extrachromosomally inherited mitochondrial mu- 
tations in mammalian cells are essential to determine 
gene locations of mitochondrial proteins and to study 
nuclear-mitochondrial interactions in mitochondrial 
biogenesis. This paper describes the isolation and 
general properties of mutants of human HeLa cells re- 
sistant to chloramphenicol. 
2. Materials and Methods 
2.1. Strains and growth medium 
All mutants were isolated from the S3 clone of HeLa 
cells. Each resistant culture was cloned in plastic petri 
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dishes (attachment method), then recloned in semi- 
solid 0.12% agar (suspension method). All cell lines 
were maintained as monolayer cultures in MEM-E 
supplemented with 10% foetal calf serum, 100 U/ml 
penicillin, and 100 &$rnl streptomycin [9], in a 37” 
incubator with a 5% COZ atmosphere. 
2.2. Mutagenesis and isolation of mutants 
A large (75 cm’) flask was seeded with 1 X IO6 S3 
cells. After allowing the cells to attach, ethidium 
bromide was added for one cell generation, then 
washed out with 3 changes of Earle’s balanced salt 
solution, harvested by treating with 0.25% viokase 
and plated, at various cell densities, in growth medium 
containing 25 or 50 I.cg/ml of chloramphenicol. After 
resistant cells had grown to stationary phase, they 
were transferred 2-3 times and then cloned. 
2.3. Growth curves 
A number of small (25 cm2) flasks were seeded 
with 4-5 X lo4 cells each and incubated for lo-14 
days at 37’. Cells from two flasks were harvested and 
counted in a Coulter counter at approximately daily 
intervals. 
2.4. Sensitivity curves 
20 Small flasks were seeded with 4-5 X lo4 cells 
each. The following day, different concentrations 
(O-200 &ml) of chloramphenicol (CAP) were added 
to duplicate flasks. 5-6 Days later (when control flasks 
had increased to l-2 X lo6 cells, i.e., late exponential 
phase) cells were harvested and counted. 
2.5. Isolation of mitochondria 
Mitochondria were prepared by cell homogenization 
and differential centrifugation as described by Attardi 
319 
Volume 25, number 2 FEBS LETTERS September 1972 
and Attardi [IO] , except that the mitochondrial pel- 
let was washed again with STM buffer (0.01 M Tris, 
pH 7.6; 0.01 M MgClz ; 10% (w/v) sucrose) and 
finally resuspended in STM f 0.001 M 2-mercap- 
toethanol. 
2.6. Protein synthesis in isolated mitochondria 
[“HI leucine incorporation into an acid-insoluble 
product was measured at 30” in an incubation mix- 
ture containing in 0.25 ml: 50 mM Tricine, pH 7.6; 
10 mM MgCl* ; 154 mM KCl; 5 mM Na? HPO, , pH 
7.6; 2 mM EDTA; 2 mM ATP; 10 mM PEP; 50 PM of 
each amino acid (minus leucine); 25 pg/ml pyruvate 
kinase; 20 &i/ml [3H]leucine 5 1 c/m mole, and 
0.6- 1.0 mg/ml mitochondrial protein. Other addi- 
tions are as described in the tables. At intervals up to 
60 min, 0.05 ml aliquots were put on Whatman 3MM 
filter paper discs and prepared for counting in toluene 
based scintillation fluid by the method of Mans and 
Novelli [ 111. Incorporation data were calculated as 
pmoles of t3H]leucine incorporated per mg of mito- 
chondrial protein per 30 min. Protein was determined 
by the Biuret method [ 121. 
3. Results and discussion 
3.1. Isolation of mu tan ts 
To increase the mutation frequency in mitochon- 
drial DNA, cells were treated with ethidium bromide, 
an intercalating dye specific for mitochondrial DNA 
[ 13, 141. The concentrations of ethidium bromide 
used and the levels of resistance to chloramphenicol of 
a series of mutants are described in table 1. Two ethi- 
dium bromide concentrations were used, 0.05 PM (a 
level at which 90% of the cells survive), and 0.5 PM 
(50% survival). A mutated culture resistant to 25 /-@ 
ml of CAP was isolated from cells treated with the 
lower concentration of ethidium bromide (mutant cul- 
ture 294), while two cultures were obtained from cells 
treated with the higher concentration, one resistant to 
25 gg/rnl (culture 295) and another to 50 /@/ml of 
CAP (culture 296). A number of clones were isolated 
from each resistant culture and tested for growth 
characteristics and sensitivity to CAP; a representative 
clone from each group was selected for futher study, 
strains 294-l) 295- 1, and 296- 1. l%L to 3 months after 
placing ethidium bromide treated cells under selective 
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conditions, resistant cells began to appear. During 
this selective process, cells continued to grow for 
about ten days, after which most of them died. The 
remaining attached cells decreased to about a tenth 
their normal size for a variable period of time. Even- 
tually they began once again to enlarge, regain a nor- 
mal morphology, and divide. The slowness of the 
selection may result from the long time required for 
sensitive mitochondria to disappear from a cell and 
for repopulation of the cell with resistant mitochon- 
dria, assuming that only one or two mitochondria 
were originally mutated in a cell containing hundreds 
of mitochondria. This delayed expression of a mutant 
phenotype also suggests that the resistances obtained 
are not the result of an alteration in cell permeability. 
3.2. Growth and sensitivity charactetistics 
The generation times of the resistant mutants in 
the presence or absence of CAP are given in table 1. 
Exponential growth rates of mutant cells in the 
presence of CAP are approximately the same as those 
of sensitive cells in the absence of CAP. In the pres- 
ence of CAP, however, the maximal monolayer den- 
sity reached by resistant cells was 4 to 5-fold less than 
in its absence. The difference in monolayer density 
was observed when mutants were tested soon after 
cloning. More recent observation, however, shows that 
Table 1 
Growth characteristics of mutant strains. 
Mutant Ethidium Chloram- 
clone bromide phenicol 
concentra- concentra- Generation time (hr) 
tion * 
&MI 
tion ** 
(&ml) 
-CAP +CAP 
294- 1 0.05 25 30 32 
294-2 0.05 25 26 30 
294-3 0.05 25 41 41 
294-4 0.05 25 30 34 
294-5 0.05 25 31 34 
295- 1 0.5 25 28 28 
296- 1 0.5 50 28 28 
296-2 0.5 50 30 28 
296-3 0.5 50 28 28 
* Ethidium bromide concentration used to mutate S3 dells. 
** Concentration of chloramphenicol at which cells were 
isolated and cloned. 
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Fig. 1. Growth curves of S3 and 296-l. All cultures were grown in MEM-E + 10% calf serum. Solid lines refer to S3 growth curves; 
(~0) S3 control; (X-X-X) S3 + 25 pg/ml CAP; ( -o---o) S3 + 50 pg/ml CAP. Broken lines refer to 296-l growth 
curves; (A.-*-*A) 296-l control; (A---A) 296-l + 25 j&ml CAP. 
they are growing to the same density with as without 
CAP. Fig. 1 shows the growth curves for wild type S3 
and for mutant strain 296-l cells in the presence and 
absence of CAP. Wild type cells never grow exponen- 
tially in the presence of CAP but exhibit a progres- 
sively decreasing growth rate from the time they are 
plated until, after 9-10 days, growth stops altogether 
and cells begin to die. This is in contrast to reported 
effects of CAP on growth in suspension cultures, 
where the growth rate is normal for 5 days before 
growth ceases [ 151. When tested for sensitivity in vivo 
to CAP, mutants fell into two classes (fig. 2). Cells in 
one group showed complete resistance to CAP con- 
centrations less than or equal to the concentrations at 
which they were isolated (clones of cultures 295 and 
296); in the other class they are partially resistant up 
to these levels (clones of culture 294). This partial resis- 
tance is also reflected in the slightly slower growth rates 
of clones of 294 in the presence of CAP than in its ab- 
sence. All mutants cloned from the same resistant cul- 
ture showed the same sensitivity characteristics. 
3.3. Protein synthesis by isolated mitochondria 
The ability of mutant strains to grow in inhibitory 
concentrations of CAP (up to 100 @ml) could be the 
result of a mutation affecting the mitochondrial pro- 
tein synthesizing system, or one excluding the anti- 
biotic from the cell. Therefore, amino acid incorpora- 
tion into pr-otein by isolated mitochondria was studied 
in sensitive S3 cells and in three derived CAP resistant 
mutants, strains 294- 1,295- 1, and 296- 1. To ob- 
tain sufficient quantities, the cells were grown in roller 
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Fig. 2. Cell sensitivity to chloramphenicol. Cells were grown 
for 5 days, to late exponential phase, in the presence of vary- 
ing concentrations of CAP. (e-e-0) S3; (X-X--X) 
294-l; (o--o--o) 295-l; (LL-A) 296-l. 
bottles to stationary phase. Mutant cultures were 
grown both with and without CAP to determine any 
differences in incorporating activity or in sensitivity 
to CAP. In all the mitochondrial preparations, incor- 
poration was linear for 30-45 min and continued for 
at least 60 min. Table 2 presents a summary of the 
activities obtained for all the preparations and of the 
effects of CAP on incorporation. Incorporation by 
mitochondria from 295- 1 and 296- 1 cells grown 
without CAP is similar to that by wild type mito- 
chondria; however, 294- 1 mitochondria have a much 
lower specific activity. This may reflect a real differ- 
ence in these cells or it may be just an artifact of the 
preparation. Mitochondria from cells of all 3 mutants 
grown in the presence of CAP show a significant in- 
crease in specific activity, varying from 1.9 to 3.5- 
fold in the different mutants. This may be an indica- 
tion of a mechanism operating in the mutants to in- 
crease the number or the activity of ribosomes in the 
mitochondria in the presence of CAP. The resistance 
of mitochondrial protein synthesis to cycloheximide 
suggests that most of the incorporation is by the 
mitochondrial protein synthesizing system and not 
the result of cytoribosomal contamination. 
CAP inhibits incorporation in the 3 mutant mito- 
chondrial preparations much less than in wild type 
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sensitive mitochondria. The extent of inhibition of 
all 3 mutants is approximately the same. With 100 
/Ig/ml of CAP, wild type mitochondria have less than 
15% of the activity of the control. In contrast, the 
mutants show 36-48% of control activity. 100 pg/ml 
was the minimal level which gave maximal inhibition 
of incorporation. Fig. 3 shows the CAP sensitivity 
curve for mitochondrial protein synthesis from sen- 
sitive S3 cells and from the resistant mutant strain 
296- 1. These findings indicate that the resistance in 
viva of the mutants are not caused by mutations 
which decrease cell membrane permeability to CAP, 
but are the result of altered mitochondria with in- 
creased resistance. 
To exclude the possibility that the resistance of 
the mitochondria was caused by decreased permeabili- 
ty of the mitochondrial membranes to CAP, mito- 
chondria were treated with 0.01% Triton X-100, a 
nonionic detergent which disrupts mitochondrial mem- 
brane structure. That Triton disrupts the membranes 
is evident from the 1.6 to 5.4-fold increase in specific 
activity in its presence, resulting from the removal of 
permeability barriers to exogenous substrates. In the 
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Fig. 3. In vitro sensitivity of mitochondrial protein synthesis 
to chloramphenicol. Protein synthesis in vim by isolated 
mitochondria was measured as described in Methods. Reac- 
tions with varying amounts of CAP were incubated for 30 
min at 30”) samples removed and incorporation measured as 
previous1 
pmoles [ Y 
described [ 111. The 100% value for S3 was 1.35 
H]leucine/mg protein/30 min; for 296-1, it was 3.12. 
(.-o-0) s3; ( w) 296- 1 (grown + CAP). 
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Table 2 
Incorporation of [3H] leucine by isolated mitochondria. 
Treat- 
ment 
s3 294- 1 295-l 296-l 
-CAP’ -CAP +CAP -CAP +CAP -CAP +cAP 
- 
S.A.’ %3 S.A. % S.A. % S.A. % S.A. % S.A. % S.A. % 
None 1.61 100 0.520 100 0.964 100 0.985 100 8.41 100 1.36 100 2.88 100 
+50 &ml 
CAP 0.262 16.3 0.298 57.3 0.496 51.5 - - 1.18 34.6 0.575 42.3 1.33 46.2 
+lOO rg/ml 
CAP 0.204 12.7 0.219 42.1 0.356 36.9 0.477 48.4 1.22 35.8 0.490 36.0 1.17 40.6 
+200 pg/ml 
cyclo- 
heximide 1.44 89.4 0.357 68.7 0.794 82.4 0.928 94.2 3.23 94.7 1.05 77.2 2.58 89.6 
+.Ol% Triton 
x-100 2.64 100 1.52 100 3.27 100 5.33 100 9.00 100 - - 3.104 100 
+.Ol% Triton 
+ 50 fig/ml 
CAP - - 0.623 41.0 1.31 40.1 1.92 36.0 2.72 30.2 - - - 
+.Ol% Triton 
100 pg/ml 
CAP 0.186 7.0 - - _ - _ - _ _ - - 1.464 47.1 
: Specific activity is measured as pmoles of [3H] leucine incorporated/mg of mitochondrial protein/30 min. 
- or +CAP refers to the growth conditions of the cells prior to isolation of mitochondria. Each mutant culture was grown in 
medium containing the same CAP concentration as that to which it was resistant (see table 1). 
: The percent value shown is percent of control incorporation. 
Triton treatment of 296- 1 mitochondria was carried out on a different preparation of mitochondria, in which control specific 
activity was 2.01 pmoles/mg mitochondrial protein/30 min. 100 pg/ml of CAP decreased this incorporation to 52% of control. 
presence of Triton, there is some decrease in resistance 
of mutant mitochondria to CAP proportional to the in- 
crease in sensitivity of S3 mitochondria. This increase 
probably reflects the ease of entry of CAP as well as 
other compounds in detergent-treated mitochondria. It 
suggests that the mutations isolated are in the mite- 
chondrial protein synthesizing system itself, not in the 
mitochondrial membranes. 
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